Published July 18, 2022
3 views Journal article Open Access Open Access

MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma.

  • 1. Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital Würzburg, University of Würzburg, 97080 Würzburg, Germany.
  • 2. University of Würzburg
  • 3. Dipartimento di Medicina Clinica e Chirurgia, Università "Federico II" di Napoli, 80131 Naples, Italy.
  • 4. Unesco Chair for Health Education and Sustainable Development, Federico II University, 80131 Naples, Italy.
  • 5. Institute of Metabolism and System Research, University of Birmingham, Birmingham B15 2TT, UK.
  • 6. University of Birmingham
  • 7. Centre for Endocrinology, Diabetes and Metabolism (CEDAM), Birmingham Health Partners, Birmingham B15 2TT, UK.

Description

Non-coding RNAs (ncRNAs) are a type of genetic material that do not encode proteins but regulate the gene expression at an epigenetic level, such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs). The role played by ncRNAs in many physiological and pathological processes has gained attention during the last few decades, as they might be useful in the diagnosis, treatment and management of several human disorders, including endocrine and oncological diseases. Adrenocortical carcinoma (ACC) is a rare and aggressive endocrine cancer, still characterized by high mortality and morbidity due to both endocrine and oncological complications. Despite the rarity of this disease, recently, the role of ncRNA has been quite extensively evaluated in ACC. In order to better explore the role of the ncRNA in human ACC, this review summarizes the current knowledge on ncRNA dysregulation in ACC and its potential role in the diagnosis, treatment, and management of this tumor.
Enabled by The Lens

Open Access

Licence Attribution (CC BY)
Publisher Website Access full text